Wenliang Wang

Technologies

• Sono-optogenetics: A non-invasive optogenetic platform
• Ultrasound-programmable nanoparticles for targeted drug release
• RECAST as an enhanced gene delivery system
• Ultrasound-triggered anesthetic drug delivery for on-demand chronic pain management
• Non-invasive sono-optogenetic platform for deep brain neural modulation
• Liquid-phase gas nanotransducers as an ultrasound actuator and imaging reporter